FDAShortage list
FDA declares the semaglutide shortage resolved, winding down compounding
The FDA confirmed the semaglutide shortage was resolved and set deadlines for compounders to stop making copies of the branded GLP-1 drug. Because the exemption allowing 503A and 503B facilities to compound semaglutide depended on its shortage status, removal from the list narrows the legal space in which compounded and “research” semaglutide is supplied.
Source
https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortagesThe issuing body’s own page is authoritative. PepIndex records what it says and when we recorded it; where the two disagree, the source governs.
Compounds affected
Ranked vendors for Semaglutide
Every vendor and price for Semaglutide →- 1
Amino Club$5.00/mg listed · 0 Semaglutide certificates90.1of 100Extensively documentedVisit Amino Club - 2
Ascend Science1 Semaglutide certificate88.9of 100Extensively documentedVisit Ascend Science - 3NLNorthline Labs$4.50/mg listed · 1 Semaglutide certificate87.7of 100Extensively documentedVisit Northline Labs
Ranked on this compound's price per mg against the market median, with testing and documentation counted as they are overall. A regulatory action against a vendor is recorded on that vendor's profile and counts against its score.